Calcinosis cutis: part II. Treatment options
Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical trials on its treatment. The efficacy of calcinosis treatment has only been reported in single cases or small case series. No treatment has been generally accepted as standard therapy, although various treatm...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Dermatology 2011-07, Vol.65 (1), p.15-22; quiz 23-4 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 22; quiz 23-4 |
|---|---|
| container_issue | 1 |
| container_start_page | 15 |
| container_title | Journal of the American Academy of Dermatology |
| container_volume | 65 |
| creator | Reiter, Nadine El-Shabrawi, Laila Leinweber, Bernd Berghold, Andrea Aberer, Elisabeth |
| description | Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical trials on its treatment. The efficacy of calcinosis treatment has only been reported in single cases or small case series. No treatment has been generally accepted as standard therapy, although various treatments have been reported to be beneficial, including warfarin, bisphosphonates, minocycline, ceftriaxone, diltiazem, aluminium hydroxide, probenecid, intralesional corticosteroids, intravenous immunoglobulin, curettage, surgical excision, carbon dioxide laser, and extracorporeal shock wave lithotripsy. |
| doi_str_mv | 10.1016/j.jaad.2010.08.039 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_872438853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>872438853</sourcerecordid><originalsourceid>FETCH-LOGICAL-p210t-3739f9d21abb07fe857e8bba0926703b1f8c9100bfbd39e6c009880d2fce1a623</originalsourceid><addsrcrecordid>eNo1j0tLxDAUhYMgzjj6B1xId25svTeZycOdFB-FATfjuiRpAil92aQL_70Fx9WBw8fHOYTcIRQIyJ_aotW6KSisBcgCmLogWwQlci6k2JDrGFsAUHsmrsiGIhdKIm7JY6k7G4YxhpjZJYX4nE16TllVFdlpdjr1bkjZOKUwDvGGXHrdRXd7zh35ens9lR_58fO9Kl-O-UQRUs4EU141FLUxILyTB-GkMRoU5QKYQS-tQgDjTcOU43bdJSU01FuHmlO2Iw9_3mkevxcXU92HaF3X6cGNS6yloHsm5YGt5P2ZXEzvmnqaQ6_nn_r_IPsF6BhQNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>872438853</pqid></control><display><type>article</type><title>Calcinosis cutis: part II. Treatment options</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Reiter, Nadine ; El-Shabrawi, Laila ; Leinweber, Bernd ; Berghold, Andrea ; Aberer, Elisabeth</creator><creatorcontrib>Reiter, Nadine ; El-Shabrawi, Laila ; Leinweber, Bernd ; Berghold, Andrea ; Aberer, Elisabeth</creatorcontrib><description>Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical trials on its treatment. The efficacy of calcinosis treatment has only been reported in single cases or small case series. No treatment has been generally accepted as standard therapy, although various treatments have been reported to be beneficial, including warfarin, bisphosphonates, minocycline, ceftriaxone, diltiazem, aluminium hydroxide, probenecid, intralesional corticosteroids, intravenous immunoglobulin, curettage, surgical excision, carbon dioxide laser, and extracorporeal shock wave lithotripsy.</description><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2010.08.039</identifier><identifier>PMID: 21679811</identifier><language>eng</language><publisher>United States</publisher><subject>Biopsy, Needle ; Calcinosis - diagnosis ; Calcinosis - drug therapy ; Calcinosis - surgery ; Ceftriaxone - therapeutic use ; Combined Modality Therapy ; Drug Therapy, Combination ; Education, Medical, Continuing ; Evidence-Based Medicine ; Female ; Humans ; Immunoglobulins, Intravenous - therapeutic use ; Immunohistochemistry ; Laser Therapy - methods ; Lasers, Gas - therapeutic use ; Male ; Minocycline - therapeutic use ; Prognosis ; Recurrence ; Risk Assessment ; Severity of Illness Index ; Skin Diseases - diagnosis ; Skin Diseases - drug therapy ; Skin Diseases - surgery ; Treatment Outcome ; Warfarin - therapeutic use</subject><ispartof>Journal of the American Academy of Dermatology, 2011-07, Vol.65 (1), p.15-22; quiz 23-4</ispartof><rights>Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21679811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reiter, Nadine</creatorcontrib><creatorcontrib>El-Shabrawi, Laila</creatorcontrib><creatorcontrib>Leinweber, Bernd</creatorcontrib><creatorcontrib>Berghold, Andrea</creatorcontrib><creatorcontrib>Aberer, Elisabeth</creatorcontrib><title>Calcinosis cutis: part II. Treatment options</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical trials on its treatment. The efficacy of calcinosis treatment has only been reported in single cases or small case series. No treatment has been generally accepted as standard therapy, although various treatments have been reported to be beneficial, including warfarin, bisphosphonates, minocycline, ceftriaxone, diltiazem, aluminium hydroxide, probenecid, intralesional corticosteroids, intravenous immunoglobulin, curettage, surgical excision, carbon dioxide laser, and extracorporeal shock wave lithotripsy.</description><subject>Biopsy, Needle</subject><subject>Calcinosis - diagnosis</subject><subject>Calcinosis - drug therapy</subject><subject>Calcinosis - surgery</subject><subject>Ceftriaxone - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Drug Therapy, Combination</subject><subject>Education, Medical, Continuing</subject><subject>Evidence-Based Medicine</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunohistochemistry</subject><subject>Laser Therapy - methods</subject><subject>Lasers, Gas - therapeutic use</subject><subject>Male</subject><subject>Minocycline - therapeutic use</subject><subject>Prognosis</subject><subject>Recurrence</subject><subject>Risk Assessment</subject><subject>Severity of Illness Index</subject><subject>Skin Diseases - diagnosis</subject><subject>Skin Diseases - drug therapy</subject><subject>Skin Diseases - surgery</subject><subject>Treatment Outcome</subject><subject>Warfarin - therapeutic use</subject><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tLxDAUhYMgzjj6B1xId25svTeZycOdFB-FATfjuiRpAil92aQL_70Fx9WBw8fHOYTcIRQIyJ_aotW6KSisBcgCmLogWwQlci6k2JDrGFsAUHsmrsiGIhdKIm7JY6k7G4YxhpjZJYX4nE16TllVFdlpdjr1bkjZOKUwDvGGXHrdRXd7zh35ens9lR_58fO9Kl-O-UQRUs4EU141FLUxILyTB-GkMRoU5QKYQS-tQgDjTcOU43bdJSU01FuHmlO2Iw9_3mkevxcXU92HaF3X6cGNS6yloHsm5YGt5P2ZXEzvmnqaQ6_nn_r_IPsF6BhQNg</recordid><startdate>201107</startdate><enddate>201107</enddate><creator>Reiter, Nadine</creator><creator>El-Shabrawi, Laila</creator><creator>Leinweber, Bernd</creator><creator>Berghold, Andrea</creator><creator>Aberer, Elisabeth</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201107</creationdate><title>Calcinosis cutis: part II. Treatment options</title><author>Reiter, Nadine ; El-Shabrawi, Laila ; Leinweber, Bernd ; Berghold, Andrea ; Aberer, Elisabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p210t-3739f9d21abb07fe857e8bba0926703b1f8c9100bfbd39e6c009880d2fce1a623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biopsy, Needle</topic><topic>Calcinosis - diagnosis</topic><topic>Calcinosis - drug therapy</topic><topic>Calcinosis - surgery</topic><topic>Ceftriaxone - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Drug Therapy, Combination</topic><topic>Education, Medical, Continuing</topic><topic>Evidence-Based Medicine</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunohistochemistry</topic><topic>Laser Therapy - methods</topic><topic>Lasers, Gas - therapeutic use</topic><topic>Male</topic><topic>Minocycline - therapeutic use</topic><topic>Prognosis</topic><topic>Recurrence</topic><topic>Risk Assessment</topic><topic>Severity of Illness Index</topic><topic>Skin Diseases - diagnosis</topic><topic>Skin Diseases - drug therapy</topic><topic>Skin Diseases - surgery</topic><topic>Treatment Outcome</topic><topic>Warfarin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reiter, Nadine</creatorcontrib><creatorcontrib>El-Shabrawi, Laila</creatorcontrib><creatorcontrib>Leinweber, Bernd</creatorcontrib><creatorcontrib>Berghold, Andrea</creatorcontrib><creatorcontrib>Aberer, Elisabeth</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reiter, Nadine</au><au>El-Shabrawi, Laila</au><au>Leinweber, Bernd</au><au>Berghold, Andrea</au><au>Aberer, Elisabeth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calcinosis cutis: part II. Treatment options</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2011-07</date><risdate>2011</risdate><volume>65</volume><issue>1</issue><spage>15</spage><epage>22; quiz 23-4</epage><pages>15-22; quiz 23-4</pages><eissn>1097-6787</eissn><abstract>Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical trials on its treatment. The efficacy of calcinosis treatment has only been reported in single cases or small case series. No treatment has been generally accepted as standard therapy, although various treatments have been reported to be beneficial, including warfarin, bisphosphonates, minocycline, ceftriaxone, diltiazem, aluminium hydroxide, probenecid, intralesional corticosteroids, intravenous immunoglobulin, curettage, surgical excision, carbon dioxide laser, and extracorporeal shock wave lithotripsy.</abstract><cop>United States</cop><pmid>21679811</pmid><doi>10.1016/j.jaad.2010.08.039</doi></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1097-6787 |
| ispartof | Journal of the American Academy of Dermatology, 2011-07, Vol.65 (1), p.15-22; quiz 23-4 |
| issn | 1097-6787 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_872438853 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Biopsy, Needle Calcinosis - diagnosis Calcinosis - drug therapy Calcinosis - surgery Ceftriaxone - therapeutic use Combined Modality Therapy Drug Therapy, Combination Education, Medical, Continuing Evidence-Based Medicine Female Humans Immunoglobulins, Intravenous - therapeutic use Immunohistochemistry Laser Therapy - methods Lasers, Gas - therapeutic use Male Minocycline - therapeutic use Prognosis Recurrence Risk Assessment Severity of Illness Index Skin Diseases - diagnosis Skin Diseases - drug therapy Skin Diseases - surgery Treatment Outcome Warfarin - therapeutic use |
| title | Calcinosis cutis: part II. Treatment options |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A58%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calcinosis%20cutis:%20part%20II.%20Treatment%20options&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Reiter,%20Nadine&rft.date=2011-07&rft.volume=65&rft.issue=1&rft.spage=15&rft.epage=22;%20quiz%2023-4&rft.pages=15-22;%20quiz%2023-4&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2010.08.039&rft_dat=%3Cproquest_pubme%3E872438853%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=872438853&rft_id=info:pmid/21679811&rfr_iscdi=true |